These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35184706)

  • 1. A
    Lambertucci C; Marucci G; Catarzi D; Colotta V; Francucci B; Spinaci A; Varano F; Volpini R
    Curr Med Chem; 2022 Aug; 29(28):4780-4795. PubMed ID: 35184706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The belated US FDA approval of the adenosine A
    Chen JF; Cunha RA
    Purinergic Signal; 2020 Jun; 16(2):167-174. PubMed ID: 32236790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pharmacological Potential of Adenosine A
    Mori A; Chen JF; Uchida S; Durlach C; King SM; Jenner P
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's disease.
    Paton DM
    Drugs Today (Barc); 2020 Feb; 56(2):125-134. PubMed ID: 32163528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the adenosine A
    Zhao Y; Zhou YG; Chen JF
    Chin J Traumatol; 2024 May; 27(3):125-133. PubMed ID: 37679245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A2A receptors and neuroprotection.
    Ongini E; Adami M; Ferri C; Bertorelli R
    Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A
    Merighi S; Borea PA; Varani K; Vincenzi F; Jacobson KA; Gessi S
    Curr Med Chem; 2022; 29(24):4138-4151. PubMed ID: 34844537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
    Cacciari B; Spalluto G; Federico S
    Mini Rev Med Chem; 2018; 18(14):1168-1174. PubMed ID: 29692248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do caffeine and more selective adenosine A
    Chen JF; Schwarzschild MA
    Parkinsonism Relat Disord; 2020 Nov; 80 Suppl 1(Suppl 1):S45-S53. PubMed ID: 33349580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective adenosine A2A receptor antagonists.
    Ongini E; Monopoli A; Cacciari B; Baraldi PG
    Farmaco; 2001; 56(1-2):87-90. PubMed ID: 11347973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
    Borah P; Deka S; Mailavaram RP; Deb PK
    Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
    Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
    Rivera-Oliver M; Díaz-Ríos M
    Life Sci; 2014 Apr; 101(1-2):1-9. PubMed ID: 24530739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Istradefylline: first global approval.
    Dungo R; Deeks ED
    Drugs; 2013 Jun; 73(8):875-82. PubMed ID: 23700273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system.
    Popoli P; Pepponi R
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):664-74. PubMed ID: 22963436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can adenosine A
    Jenner P; Mori A; Kanda T
    Parkinsonism Relat Disord; 2020 Nov; 80 Suppl 1():S28-S36. PubMed ID: 33349577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Substituted 2-benzylidene-1-tetralone analogues as A
    Janse van Rensburg HD; Terre'Blanche G; van der Walt MM; Legoabe LJ
    Bioorg Chem; 2017 Oct; 74():251-259. PubMed ID: 28881253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
    J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.